Inceptionr LLC Buys Shares of 4,647 Trupanion, Inc. (NASDAQ:TRUP)

Inceptionr LLC purchased a new position in Trupanion, Inc. (NASDAQ:TRUP) in the 4th quarter, HoldingsChannel reports. The institutional investor purchased 4,647 shares of the financial services provider’s stock, valued at approximately $224,000.

Several other large investors have also recently made changes to their positions in the stock. Raymond James Financial Inc. bought a new position in shares of Trupanion in the 4th quarter worth $593,000. Proficio Capital Partners LLC bought a new position in shares of Trupanion in the 4th quarter worth $976,000. Charles Schwab Investment Management Inc. raised its position in shares of Trupanion by 2.1% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 306,752 shares of the financial services provider’s stock worth $14,785,000 after acquiring an additional 6,338 shares in the last quarter. Steward Partners Investment Advisory LLC raised its position in shares of Trupanion by 12.4% in the 4th quarter. Steward Partners Investment Advisory LLC now owns 11,805 shares of the financial services provider’s stock worth $569,000 after acquiring an additional 1,300 shares in the last quarter. Finally, SBI Securities Co. Ltd. bought a new position in shares of Trupanion in the 4th quarter worth $25,000.

Insider Buying and Selling at Trupanion

In other Trupanion news, CEO Margaret Tooth sold 2,294 shares of the business’s stock in a transaction dated Tuesday, March 4th. The stock was sold at an average price of $31.39, for a total transaction of $72,008.66. Following the sale, the chief executive officer now owns 118,784 shares in the company, valued at approximately $3,728,629.76. The trade was a 1.89 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO Fawwad Qureshi sold 1,373 shares of the business’s stock in a transaction dated Wednesday, February 26th. The shares were sold at an average price of $34.22, for a total value of $46,984.06. Following the sale, the chief financial officer now owns 2,416 shares in the company, valued at approximately $82,675.52. The trade was a 36.24 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 3,859 shares of company stock worth $128,593. 5.50% of the stock is currently owned by insiders.

Trupanion Stock Down 1.5 %

Shares of TRUP stock opened at $32.46 on Tuesday. Trupanion, Inc. has a 1-year low of $19.69 and a 1-year high of $57.90. The stock’s fifty day moving average price is $43.80 and its 200 day moving average price is $47.42. The company has a debt-to-equity ratio of 0.39, a current ratio of 1.71 and a quick ratio of 1.66. The company has a market cap of $1.38 billion, a price-to-earnings ratio of -141.13, a price-to-earnings-growth ratio of 6.02 and a beta of 1.70.

Trupanion (NASDAQ:TRUP) last posted its quarterly earnings results on Wednesday, February 19th. The financial services provider reported $0.04 earnings per share for the quarter, missing the consensus estimate of $0.06 by ($0.02). The firm had revenue of $337.31 million for the quarter, compared to analysts’ expectations of $335.41 million. Trupanion had a negative net margin of 0.75% and a negative return on equity of 3.08%. On average, research analysts expect that Trupanion, Inc. will post 0.13 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several research analysts have recently commented on TRUP shares. Stifel Nicolaus reduced their price target on Trupanion from $44.00 to $41.00 and set a “hold” rating for the company in a research report on Thursday, February 20th. Piper Sandler dropped their target price on Trupanion from $57.00 to $52.00 and set an “overweight” rating on the stock in a research note on Thursday, February 20th. Two equities research analysts have rated the stock with a hold rating, four have given a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, Trupanion has an average rating of “Moderate Buy” and an average price target of $46.60.

Trupanion Profile

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.